Priority Date: 20.12.11 (US 201161578000P)

SINGLE DOMAIN ANTIBODIES AS INHIBITORS OF PCSK9

  • Application ID: EP12859390
  • Status: EXAMINATION IN PROGRESS

Applicant

Research organisation logo small
Research Organisation

Attorney

Company dna icosa
no operation time available
646.12
1 office
active in Legal Services

Specialization

This EP application has the IPC class A61, C07, C12, and G01. Icosa is specialized in the combination A61, C07, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Potter Clarkson LLP and 56 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 20.12.2011 - Priority Date (US 201161578000P)
  • 27.06.2013 - Publication A1 (WO2013091103)
  • 29.10.2014 - Publication A1 (EP2794661)